Literature DB >> 11096690

Essential Tremor.

.   

Abstract

Multiple pharmacologic treatments have been studied, but propranolol and primidone have proven to be the most effective medications. It is unlikely that a patient will respond miraculously to another medication if his or her response to propranolol and primidone is minimal. Some subsets of essential tremor, however, such as the kinetic predominant type, may respond better to other medications. Mildly affected patients may not need treatment at all, and the potential benefits must always be weighed against the possible side effects. The main benefit of botulinum toxin injection is for head tremor, whereas its efficacy in hand tremor is variable. If a patient does not respond to adequate doses of propranolol or primidone, deep brain stimulation should be considered because it carries the lowest risk of the available surgical procedures; usually, it should be given preference over thalamotomy. It is important for the physician to realize the multitude of symptomatic treatments available. Beyond the conventional and often effective oral medications, use of newer treatments such as botulinum toxin, thalamotomy, and deep brain stimulation can often reduce tremor and lead to a greater quality of life for patients with ET.

Entities:  

Year:  1999        PMID: 11096690     DOI: 10.1007/s11940-999-0027-3

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  44 in total

1.  [Not Available].

Authors:  E KATZENSTEIN
Journal:  Schweiz Arch Neurol Psychiatr       Date:  1948

2.  Treatment of essential tremor with arotinolol.

Authors:  Y Kuroda; R Kakigi; H Shibasaki
Journal:  Neurology       Date:  1988-04       Impact factor: 9.910

3.  Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor.

Authors:  J Wissel; F Masuhr; L Schelosky; G Ebersbach; W Poewe
Journal:  Mov Disord       Date:  1997-09       Impact factor: 10.338

4.  The effect of nimodipine on essential tremor.

Authors:  N Biary; Y Bahou; M A Sofi; W Thomas; S M al Deeb
Journal:  Neurology       Date:  1995-08       Impact factor: 9.910

5.  Metoprolol compared with propranolol in the treatment of essential tremor.

Authors:  W C Koller; N Biary
Journal:  Arch Neurol       Date:  1984-02

6.  A double-blind trial of clonazepam in benign essential tremor.

Authors:  C Thompson; A Lang; J D Parkes; C D Marsden
Journal:  Clin Neuropharmacol       Date:  1984       Impact factor: 1.592

7.  Dose-response relationship of propranolol in the treatment of essential tremor.

Authors:  W C Koller
Journal:  Arch Neurol       Date:  1986-01

8.  Botulinum toxin A injections for the treatment of hand tremors.

Authors:  R M Trosch; S L Pullman
Journal:  Mov Disord       Date:  1994-11       Impact factor: 10.338

9.  Essential tremor: clinical correlates in 350 patients.

Authors:  J S Lou; J Jankovic
Journal:  Neurology       Date:  1991-02       Impact factor: 9.910

10.  Is essential tremor benign?

Authors:  K L Busenbark; J Nash; S Nash; J P Hubble; W C Koller
Journal:  Neurology       Date:  1991-12       Impact factor: 9.910

View more
  10 in total

1.  Cerebellar Ataxia.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

Review 2.  The emerging neuropathology of essential tremor.

Authors:  Elan D Louis; Jean Paul G Vonsattel
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

3.  Relationship between blood harmane and harmine concentrations in familial essential tremor, sporadic essential tremor and controls.

Authors:  Elan D Louis; Wendy Jiang; Marina Gerbin; Mary M Mullaney; Wei Zheng
Journal:  Neurotoxicology       Date:  2010-08-11       Impact factor: 4.294

Review 4.  Management of essential tremor.

Authors:  Theresa A Zesiewicz; Elmyra Encarnacion; Robert A Hauser
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

5.  Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor: repeat observation in cases and controls in New York.

Authors:  Elan D Louis; Wendy Jiang; Marina Gerbin; Amanda S Viner; Pam Factor-Litvak; Wei Zheng
Journal:  J Toxicol Environ Health A       Date:  2012

6.  Fertility in essential tremor. Data from population-based and clinical sources.

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2008-09-11       Impact factor: 3.282

Review 7.  Environmental epidemiology of essential tremor.

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2008-08-21       Impact factor: 3.282

8.  Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor.

Authors:  Elan D Louis; Wendy Jiang; Kathryn M Pellegrino; Eileen Rios; Pam Factor-Litvak; Claire Henchcliffe; Wei Zheng
Journal:  Neurotoxicology       Date:  2007-12-27       Impact factor: 4.294

Review 9.  Beta-carboline alkaloids and essential tremor: exploring the environmental determinants of one of the most prevalent neurological diseases.

Authors:  Elan D Louis; Wei Zheng
Journal:  ScientificWorldJournal       Date:  2010-09-01

10.  [The use of neuromodulation for the treatment of tremor].

Authors:  Damián Bendersky; Pablo Ajler; Claudio Yampolsky
Journal:  Surg Neurol Int       Date:  2014-08-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.